Breaking News
November 21, 2018 - FDA Alert: Gilenya (fingolimod): Drug Safety Communication
November 21, 2018 - Uric Acid Test: MedlinePlus Lab Test Information
November 21, 2018 - Researchers use genetics to predict response to antipsychotic medications
November 21, 2018 - Proposal to include the price of drugs in television ads is flawed, Stanford scholar writes
November 21, 2018 - Disrupting reproduction strategy of disease-causing parasites could help fight malaria
November 20, 2018 - ACAAI: Almost 2 Percent of Children Have Milk Allergy
November 20, 2018 - Congenital anomalies of kidney and urinary tract – Genetics Home Reference
November 20, 2018 - Can video games improve the health of older adults with schizophrenia?
November 20, 2018 - Can flicking a molecular switch restore the aging immune system’s competence?
November 20, 2018 - Restek launches new Oregon cannabis pesticide standards
November 20, 2018 - Health sector coalition urges Government to safeguard patients in future UK-EU relationship
November 20, 2018 - Study evaluates second-hand marijuana smoke exposure among children
November 20, 2018 - Scientists identify three genes responsible for recurrent molar pregnancies
November 20, 2018 - Researchers identify multisystem disorder caused by bi-allelic variants in CCDC47 gene
November 20, 2018 - Dining Out With Allergies Is Tough, But These Steps Can Help
November 20, 2018 - Breastfeeding protects infants from antibiotic-resistant bacteria
November 20, 2018 - AI matched, outperformed radiologists in screening X-rays for certain diseases | News Center
November 20, 2018 - Adolescents increasingly choose marijuana over cigarettes, alcohol
November 20, 2018 - World’s first medical imaging scanner produces diagnostic scan of the whole human body
November 20, 2018 - Cytocybernetics receives NIMH award to move into neuronal drug development
November 20, 2018 - ‘Unknown’ enzyme may be key to new treatment for inflammatory diseases
November 20, 2018 - Recreational drug may help people regain trust in others
November 20, 2018 - Researchers identify gene vital for post-stroke recovery
November 20, 2018 - Scientists identify novel target for neuron regeneration, functional recovery in spinal cord injury
November 20, 2018 - Potential new therapeutic approach developed for synovial sarcoma
November 20, 2018 - Skeletal imitation reveals how bones grow atom-by-atom
November 20, 2018 - Autism behaviors show unique brain network fingerprints in infants
November 20, 2018 - Location matters for inflammation clearance
November 20, 2018 - Towards finding a druggable cancer target
November 20, 2018 - Ultragenyx Announces Intent to Submit New Drug Application to U.S. FDA for UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Mid-2019
November 20, 2018 - Cooling ‘brains on fire’ to treat Parkinson’s
November 20, 2018 - Less pollution could increase the average lifespan of Copenhageners by an entire year in 2040
November 20, 2018 - Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network
November 20, 2018 - The plug and play time-resolved spectrometer from PicoQuant
November 20, 2018 - Breakthrough technology offers new hope to people with glaucoma, retinitis and macular degeneration
November 20, 2018 - New report highlights key focus areas to help cancer screening realize its full potential
November 20, 2018 - International experts to discuss strategies to maintain spatial orientation in old age
November 20, 2018 - Low-protein, high-carb diet may promote healthy brain ageing
November 20, 2018 - Scientists discover new inhibitor that decreases lung inflammation
November 20, 2018 - Participation project calls for relaxing research ban on germline interventions
November 20, 2018 - Karyopharm’s Selinexor Receives Fast Track Designation from FDA for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma
November 20, 2018 - Arthritis by the Numbers: Book of Trusted Facts & Figures
November 20, 2018 - Drug homing method helps rethink Parkinson’s
November 20, 2018 - AHF commends the passage of global AIDS funding in the House, calls for swift approval
November 20, 2018 - The search for new psychiatric disorder treatments
November 20, 2018 - New research offers hope for simpler way to diagnose and treat cancer
November 20, 2018 - Study sheds light on the infection mechanism of influenza virus
November 20, 2018 - Storage failures of eggs and embryos gain a new perspective
November 20, 2018 - Buyers of short-term health plans: Wise or shortsighted?
November 20, 2018 - Study indicates that frogs in virus-exposed groups breed at young age
November 20, 2018 - FDA Alerts Health Care Professionals and Patients Not To Use Sterile Drug Products from Pharm D Solutions
November 20, 2018 - Asthma may contribute to childhood obesity epidemic
November 20, 2018 - Live probiotics can change existing gut flora and alter immune response
November 20, 2018 - Researchers to explore the enigmatic role of unstructured protein in regulating circadian function
November 20, 2018 - Many patients with adenomas do not receive colonoscopy within recommended time frame
November 20, 2018 - Drug used to treat PTSD does not reduce suicidal thinking, may worsen nightmares and insomnia
November 20, 2018 - In-person social contact may offer protection against depression and PTSD symptoms
November 20, 2018 - Routine HCV testing in correctional facilities can best identify and treat disease, say researchers
November 20, 2018 - Molecular DNA analysis could facilitate more accurate prognosis, treatment of aggressive brain tumors
November 20, 2018 - Breast Cancer Recurrence Rate Not Up With Autologous Fat Transfer
November 20, 2018 - Beta 2 Microglobulin (B2M) Tumor Marker Test: MedlinePlus Lab Test Information
November 20, 2018 - Could bariatric surgery make men more virile?
November 20, 2018 - Urine test to check if patients take their medications will save the NHS money, say researchers
November 20, 2018 - Study reveals impact of residual inflammatory risk on clinical outcomes after PCI
November 20, 2018 - RNAi therapy shown to alleviate preeclampsia
November 20, 2018 - Replacement of dysfunctional microglia has therapeutic potential for neurodegenerative diseases
November 20, 2018 - Forming 3D Neuronal Models of the Brain
November 20, 2018 - Shoulder ultrasounds could be used to predict diabetes
November 20, 2018 - SGLT2 Inhibitors for Diabetes Linked to Increased Risk for Amputation
November 20, 2018 - Stem cell transplant cements Arizona men’s father-son bond
November 20, 2018 - Scientists try to develop portable systems that can quickly produce biologics on demand
November 20, 2018 - Automating Data Capture and Image Analysis in Continuous Experiments
November 20, 2018 - New drug shows promise for treating people with peanut allergy
November 20, 2018 - Researchers develop novel mouse model to study immunomodulatory therapies
November 20, 2018 - “Britain must not go backward on antibiotic controls to appease US trade deals” – Jim Moseley, CEO of Red Tractor
November 20, 2018 - Widespread errors in ‘proofreading’ cause inherited blindness
November 20, 2018 - Reaping the benefits of living longer
November 20, 2018 - New Program Hopes to Make Early Detection and Treatment of ALS a Reality
November 19, 2018 - Artificial bone-like substance mimics the way real bone grows at atomic level
November 19, 2018 - FDA Grants Orphan Drug Designation To RGX-181 Gene Therapy For The Treatment Of CLN2 Form Of Batten Disease
Scientists identify how viral protein promotes fatal disease caused by Nipah and Hendra viruses

Scientists identify how viral protein promotes fatal disease caused by Nipah and Hendra viruses

image_pdfDownload PDFimage_print

Researchers have identified how a viral protein, which plays a major role in causing deadly Nipah and Hendra virus infections, targets a critical function in human cells to suppress immune responses and promote fatal disease.

The research team found the viral protein, called W protein, binds to two specific proteins in the host cell, importin α3 and importin α4, allowing it to move into the nucleus of cells. This allows the protein to disable defenses that protect cells from infection and promote growth of Nipah and Hendra viruses. The findings are published in the journal Nature Communications.

Nipah and Hendra viruses, closely related zoonotic pathogens that come from animal sources, are highly lethal in humans. Old World fruit bats are the source of both viruses in nature.

Hendra virus infections have been identified in Australia, mostly in veterinarians who were caring for horses. Scientists believe the virus passed from bats to horses, and then veterinarians came in contact with the sick horses.

Nipah virus was originally discovered in Malaysia in 1998. There was an outbreak of encephalitis, one of the symptoms of Nipah virus, in people working on pig farms. Scientists believe bats transmitted the virus to these pigs, and then people who came in contact with the infected pigs became sick. Forty percent of the people who became ill died. More recently, Nipah virus infections have been recognized in Bangladesh and India, with 70 to 75 percent fatality rates. This time, there seems to be a more direct transmission of the virus from bats to people.

“Right now, for humans, we lack any licensed vaccines or approved drugs to treat the infections,” said Dr. Christopher Basler, senior author of the study, professor in the Institute for Biomedical Sciences and director of the Center for Microbial Pathogenesis at Georgia State University and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis. “We need vaccines, we need treatments, and we also need to better understand what makes the viruses so deadly.

“The protein we’re studying is called the W protein. We’ve been studying this protein for several years because it suppresses innate immune responses. This means that it blocks the very early defenses that should protect us from virus infection.”

In previous work, Basler and his colleagues at the University of Texas Medical Branch at Galveston have studied the behavior of Nipah virus in animals. They wanted to understand how important W protein is for the ability of the virus to cause disease. Using facilities at University of Texas Medical Branch at Galveston, they engineered a Nipah virus that couldn’t produce the W protein and then put this modified virus into animals. This changed the course of disease and demonstrated that the function of the W protein is important for Nipah virus to cause disease.

In this study, a research team led by Dr. Jade K. Forwood of Charles Sturt University in Australia used structural biology approaches to investigate how the W protein travels from the cytoplasm to the nucleus of the cell through the interaction of W protein with importin α proteins, which allow the W protein to get into the nucleus. The Basler laboratory at Georgia State performed studies in living cells to investigate the W protein interaction with importin α proteins and define why this interaction is important for W protein function. In prior work, Basler has found the ability of the W protein to enter into the nucleus is important for its ability to block innate immune responses.

“One of the things that’s interesting about the W protein being in the nucleus of the cell is that most of the other components of the virus remain in the cytoplasm of the cell throughout the replication cycle,” Basler said. “We think that the W protein goes to the nucleus to do something, to somehow specifically target innate immune responses.”

Human cells have seven different kinds of importin α proteins. In this study, the researchers found W protein is using two of them, importin α3 and importin α4, to get into the nucleus. They identified specific features on the W protein that allow it to recognize those two members of the importin α protein family and distinguish them from others.

“We’re trying to understand how it selectively uses two of the seven family members for this,” Basler said. “There’s a broader biological question there. We don’t really understand how this selectivity works or even really why it’s important. We’re trying to better understand the basis of that selectivity.

“I think you can argue that by understanding this, it may suggest strategies by which we can try to block the interaction between the viral protein (W) and the host protein (importin) that might be useful in terms of developing therapies that are designed to block this virus. If you had a drug that somehow prevented that interaction, W would no longer carry on its normal function and that would attenuate the virus and make it less able to cause disease.”

Tagged with:

About author

Related Articles